Facial Implants: The Bone-Level Answer That Filler Has Been Standing In For

A patient walks into a consultation and asks for cheekbones. Or a jaw angle. Or the thing they have been shown a hundred times on a feed, where the side of a face turns and catches light along a hard line that runs from ear to chin.

What they are usually offered is filler. Two syringes at the malar eminence, two or three along the mandibular border, an appointment that takes twenty minutes and a result they can see in the mirror before they reach the parking lot. What they are asking for, anatomically, is more bone. Facial implants are the category built to supply it, and for most of the last decade they have been the quieter option in a market that prefers what it can sell on a Tuesday afternoon.

That gap is worth examining, because the two things are not competing versions of the same treatment. They are answers to different questions, and the one being asked more often is the one being answered less honestly.

Filler is a soft tissue answer to a skeletal question

The short answer: a cheekbone and a jaw angle are bone, filler sits above bone in soft tissue, and the difference shows up in how the result behaves rather than in how it photographs at two weeks.

Malar projection comes from the zygoma. Jaw definition comes from the mandibular angle, the gonial flare, and the width of the ramus. When those structures are small or set back, the overlying soft tissue drapes without a shelf underneath it. Injecting hyaluronic acid onto the periosteum can create the visual impression of a shelf, and in modest amounts, in a patient with reasonable underlying structure, it works well enough that it has become the default.

The problems arrive with volume and with time. Filler is a gel that responds to gravity, animation, and the mechanical realities of the plane it sits in. It does not always stay where it was placed, a behavior explored in detail in where filler actually goes. Repeated large-volume placement over years produces the heavy, wide, slightly indistinct midface that the market has learned to recognize on sight and does not have a polite name for. And the economics are quietly brutal: a syringe-based approach to a structural deficiency is an annual or biannual expense with no terminal state, which over ten or fifteen years frequently exceeds the one-time cost of an operation that would have addressed the actual anatomy.

An implant does not have those properties. It is a solid object placed directly on bone, usually under the periosteum, and it stays the size and shape it was on the day it went in. That is the entire argument for it, and it is a good one for the specific patient whose deficiency is skeletal rather than volumetric.

"

Filler placed on the cheekbone is not a smaller version of a cheek implant. It is a soft tissue solution to a bone problem, and after enough syringes the face starts to look like exactly that.

"

What is actually being implanted, and why the material decides the revision

The short answer: the two dominant materials are solid silicone and porous polyethylene, they behave in opposite ways inside the face, and the difference matters most on the day someone wants the implant out.

Solid silicone is not the gel inside a breast implant. It is a firm, carvable elastomer block. The body walls it off in a fibrous capsule and does not grow into it. That means it can be repositioned during surgery, exchanged, or removed years later with relative ease, which is a genuine advantage that surgeons who favor it will name first. The trade-off is that an object sitting in a smooth capsule can shift if it is not fixed in place, and long-standing silicone implants pressing against bone have been documented radiographically to cause underlying bone resorption, a saucer-shaped depression beneath the implant. This is best described for chin implants and is generally reported as clinically silent, but it is real and it is one reason screw fixation and careful pocket design have become standard practice rather than optional refinements.

Porous polyethylene, sold most commonly under the brand Medpor, is the opposite proposition. Its pore structure permits fibrovascular tissue to grow into the material. The implant becomes mechanically integrated with the surrounding tissue, which makes migration far less likely and makes some surgeons prefer it in the mandible, where forces are higher. The cost of that stability is that removal is no longer a matter of opening the pocket and lifting something out. Taking out an integrated porous implant means dissecting it away from tissue that has grown through it, which is a harder operation with more collateral damage, and it is not a step patients are typically walked through before they consent.

Both categories are regulated as devices cleared through the FDA 510(k) pathway, which establishes substantial equivalence to a predicate device rather than proving a clinical benefit. That is standard for implantable facial hardware and not itself a criticism. It does mean that the regulatory status of the object in the pocket says nothing about whether the aesthetic result will hold, a distinction that recurs throughout this field.

Custom implants are a real advance carrying a thin evidence base

The short answer: implants designed from a patient's own CT data solve genuine problems that off-the-shelf sizes cannot, and the outcome claims attached to them run well ahead of the published comparative data.

The traditional implant comes in a manufacturer's size range, small through large, in a shape derived from an average face. A surgeon selects the closest fit and carves it during the operation. That works, and it has worked for decades, but it requires the patient's asymmetry and skeletal anatomy to be reasonably close to average, and real faces frequently are not.

A patient-specific implant starts from a CT or cone beam scan. The scan becomes a three dimensional model, the implant is designed on that model to seat against the patient's actual bone contours, and it is manufactured to that design. The benefits are logical and, for complex cases, substantial: precise seating with no rocking, the ability to correct genuine asymmetry rather than augment both sides identically, continuous contour across the jawline rather than discrete blocks at the angle and chin, and shorter intraoperative carving time. For patients with significant congenital asymmetry, prior trauma, or a previous reconstruction, this is not a luxury feature.

What is missing is the comparison. There is very little published work that randomizes or even prospectively matches custom implants against well-executed off-the-shelf implants for straightforward cosmetic augmentation, tracks both groups for years, and reports revision rates side by side. The case series that exist are favorable and mostly come from the surgeons and centers who adopted the technology. Meanwhile the price differential is large, often several thousand dollars in design and manufacturing before any surgical fee, and the lead time runs weeks. That does not make the category oversold. It makes the honest version of the recommendation sound like this: your anatomy specifically requires it, or your anatomy does not and this is a preference you are paying a premium for. Patients deserve to be told which sentence applies to them. The general problem of a technology reaching the market faster than the evidence supporting it is a recurring pattern in this industry.

The complication list is short, specific, and mostly about position

The short answer: facial implants have a low overall complication rate, and the failures that do occur cluster into malposition, infection, and nerve injury rather than into anything exotic.

Malposition is the most common reason a well-performed implant produces an unhappy patient. An implant one or two millimeters off center, or seated slightly high on the zygoma, reads as an asymmetry in every photograph even though the object itself is exactly what was ordered. This is a pocket dissection and fixation problem, and it is the main argument for screw fixation and for surgeons who do enough of these to have refined their pocket technique. It is also the reason a settled result should be judged at months, not weeks, since swelling in the midface and along the mandible resolves slowly.

Infection is uncommon but consequential, because an infected implant usually has to come out. Reported rates in the literature generally sit in the low single digits, with intraoral approaches carrying more contamination exposure than external approaches, which is one reason surgeons make different incision choices for the same implant. An implant removed for infection means a second operation, a period with an asymmetric or deflated contour, and a delay of several months before replacement can be attempted.

Nerve injury is the one patients underestimate. The infraorbital nerve runs directly through the field for a cheek implant, and the mental and marginal mandibular nerves are in play along the jaw. Temporary numbness of the cheek, upper lip, or lower lip is common and expected. Permanent alteration is uncommon but documented, and the risk profile is different from the numbness after body procedures described in what nerve recovery actually looks like, because facial sensory territory is small, specific, and difficult to ignore.

The category that never appears in a brochure is elective removal. Some patients simply do not like the result, or find the augmentation too strong once the swelling is gone, or want out a decade later as the rest of the face changes around a fixed object. Removal is a legitimate outcome and a normal part of the conversation, and it is dramatically easier with a smooth implant than with an integrated porous one. A surgeon who has never taken one out has either a very short practice history or an incomplete follow-up system, a question that connects directly to the case volume conversation.

Where implants sit against the other structural options

The short answer: an implant adds a fixed volume to an existing skeleton, and it is not a substitute for moving the skeleton itself or for treating a muscle problem that only looks like a bone problem.

The comparison patients most often need and least often get is with orthognathic surgery. Jaw surgery repositions the mandible and maxilla, changes the occlusion, and alters the airway. An implant does none of that. If the underlying issue is a retruded mandible with a functional bite problem, an angle implant makes the side profile of the jaw more visible while leaving the actual skeletal relationship untouched, a distinction laid out in what jaw surgery actually corrects. Bone contouring in the opposite direction, reduction rather than augmentation, belongs to a separate discussion covered in the bone work behind facial feminization.

There are also non-skeletal causes of a face that reads as wide or undefined. Masseter hypertrophy produces lower face width that no implant improves and that responds to a completely different intervention, discussed in what shrinking a chewing muscle actually does. Submental fat obscures a jawline that may be perfectly well built underneath it. Age-related fat pad descent is a soft tissue problem masquerading as a bone problem, and it is the single most common reason a midface implant disappoints a patient over fifty who actually needed a lift.

The chin is the exception worth naming, because it is the one facial implant with a long track record, a well understood technique, and the most reliable payoff relative to its cost, examined in why the chin decides how the profile reads. It is also the most commonly performed of the group, and by a wide margin.

The volumes tell the story of the whole category. American Society of Plastic Surgeons annual statistics have consistently placed cheek implant procedures in the low tens of thousands or fewer per year, while soft tissue filler procedures run into the millions. That ratio is not a reflection of clinical appropriateness. It reflects which procedure a practice can perform without an operating room, without anesthesia, and without a recovery period the patient has to explain at work. What each of those settings costs, and what is buried in the estimate, is unpacked in what a plastic surgery quote actually covers.

The honest summary

Facial implants are the anatomically correct answer to a skeletal deficiency, and they have been losing market share for a decade to a product that addresses a different layer of the face. That is a marketing outcome, not a clinical one. A patient whose cheekbone or jaw angle is genuinely underbuilt is being served syringes because syringes are easier to sell, easier to schedule, and easier to say yes to, and the cumulative bill over fifteen years often exceeds the operation that would have settled it.

The decisions that matter are narrower than the brochure suggests. Material choice is largely a decision about the day someone wants the implant out: smooth silicone comes out readily and can shift if it is not fixed, porous polyethylene stays put and is genuinely difficult to remove. Custom implants earn their premium in asymmetry, complex anatomy, and revision, and in a routine symmetric augmentation they are a preference rather than a requirement, with no strong comparative data saying otherwise. Malposition, not catastrophe, is the realistic failure mode, and it is a technique and fixation problem that tracks with how many of these a surgeon actually does.

Three things belong in the consultation. Make the surgeon separate bone deficiency from soft tissue volume loss on your exam, out loud, because the wrong diagnosis produces a technically perfect implant in a face that needed something else. Ask how the implant comes out and how hard that is, before you agree to put it in. And ask for a removal and revision number alongside the placement number, because a practice that only counts what it puts in is not measuring the outcome you care about.

The look being sold on a feed is a bone shape. It is worth knowing whether the treatment on the table is aimed at the bone.